DexCom
DXCM
950 hedge funds and large institutions have $27.9B invested in DexCom in 2024 Q4 according to their latest regulatory filings, with 193 funds opening new positions, 333 increasing their positions, 334 reducing their positions, and 115 closing their positions.
68% more first-time investments, than exits
New positions opened: 193 | Existing positions closed: 115
46% more call options, than puts
Call options by funds: $728M | Put options by funds: $499M
16% more capital invested
Capital invested by funds: $24.1B → $27.9B (+$3.84B)
7% more funds holding
Funds holding: 889 → 950 (+61)
2.32% more ownership
Funds ownership: 89.51% → 91.84% (+2.3%)
0% less repeat investments, than reductions
Existing positions increased: 333 | Existing positions reduced: 334
22% less funds holding in top 10
Funds holding in top 10: 9 → 7 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$339M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$224M |
| 3 |
Millennium Management
New York
|
+$202M |
| 4 |
Morgan Stanley
New York
|
+$122M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$118M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$420M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$280M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
-$265M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$118M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$107M |
DXCM Hedge Fund Activity: Q4 2024 in Review
950 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q4 2024, worth a combined $27.9B — up 16% from $24.1B a quarter earlier.
Buyers outnumbered sellers: 193 funds opened new DXCM positions and 115 closed out — a net gain of 78 holders — while 333 added to existing stakes and 334 trimmed.
The largest buyer was BlackRock, adding an estimated $339M. The largest seller was Wellington Management Group, cutting an estimated $420M.
- 950 institutional investors held DexCom (DXCM) as of Q4 2024, up from 889 in Q3 2024.
- Funds reported $27.9B of DexCom stock for Q4 2024, up 16% quarter-over-quarter.
- 193 funds opened new DexCom positions in Q4 2024 and 115 closed out, a net change of +78 holders.
- The largest DexCom buyer in Q4 2024 was BlackRock, an estimated $339M added.
- The largest DexCom seller in Q4 2024 was Wellington Management Group, an estimated $420M sold.
Based on aggregated 13F filings for Q4 2024.